Detectable Prostate-Specific Antigen Nadir During Androgen-Deprivation Therapy Predicts Adverse Prostate Cancer Specific Outcomes: Results from the SEARCH Database

BACKGROUND: A prostate-specific antigen (PSA) level <0.2 ng/ml on androgen-deprivation therapy (ADT) is correlated with better outcomes. However, not all men reach a nadir PSA level within 8 mo. Whether the lowest PSA on ADT—specifically, <0.2 ng/ml—can be used for risk stratification is untes...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Keto, Christopher J., Aronson, William J., Terris, Martha K., Presti, Joseph C., Kane, Christopher J., Amling, Christopher L., Freedland, Stephen J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3634863/
https://ncbi.nlm.nih.gov/pubmed/23245686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2012.11.052
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares